Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1-40 in a transgenic mouse model

NeuroReport

Volumn 24, Issue 1, 2013, Pages 16-21

  Kim, Jae Hun ^a   Ha, Tae Lin ^b   Im, Geun Ho ^c   Yang, Jehoon ^c   Seo, Sang Won ^a   Lee, In Su ^d   Lee, Jung Hee ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Alzheimer's disease; Amyloid plaque; Hollow manganese oxide nanoparticles; Magnetic resonance imaging

Indexed keywords

AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-40]; MANGANESE OXIDE; NANOPARTICLE; THIOFLAVINE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM CORTEX; CISTERNA MAGNA; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; IMAGE ANALYSIS; IMAGE PROCESSING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OLFACTORY CORTEX; PRIORITY JOURNAL; THALAMUS;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES; BRAIN; BRAIN MAPPING; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; MANGANESE COMPOUNDS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NANOPARTICLES; OXIDES; PEPTIDE FRAGMENTS; PLAQUE, AMYLOID; PRESENILIN-1; TIME FACTORS;

EID: 84870950486     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0b013e32835ba850     Document Type: Article

References (22)

1. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron 2001; 32: 177-180.
2. Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 1991; 12:383-388.
3. Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 2005; 25:10598-10606.
4. Forsberg A, Engler H, Blomquist G, Langstrom B, Nordberg A. The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochim Biophys Acta 2011; 1822:380-385.
5. Manook A, Yousefi BH, Willuweit A, Platzer S, Reder S, Voss A, et al. Smallanimal PET imaging of amyloid-beta plaques with [C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS One 2012; 7:e31310.
6. Rosen RF, Ciliax BJ, Wingo TS, Gearing M, Dooyema J, Lah JJ, et al. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol 2010; 119:221-233.
7. Rosen RF, Walker LC, Levine H 3rd. PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol Aging 2011; 32:223-234.
8. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci USA 1999; 96:14079-14084.
9. *-weighted MR microscopic images. NMR Biomed 2002; 15:197-203.
10. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, et al. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 2004; 51:794-798.
11. Jack CR Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 2004; 52:1263-1271.
12. Jack CR Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, et al. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 2005; 25:10041-10048.
13. Petiet A, Santin M, Bertrand A, Wiggins CJ, Petit F, Houitte D, et al. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice. Neurobiol Aging 2011; 33:1533-1544.
14. Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, et al. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging. Neurobiol Dis 2002; 11:315-329.
15. Sigurdsson EM, Wadghiri YZ, Mosconi L, Blind JA, Knudsen E, Asuni A, et al. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice. Neurobiol Aging 2008; 29:836-847.
16. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, et al. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003; 50:293-302.
17. Yang J, Wadghiri YZ, Hoang DM, Tsui W, Sun Y, Chung E, et al. Detection of amyloid plaques targeted by USPIO-Abeta1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging. Neuroimage 2011; 55:1600-1609.
18. Shin J, Anisur RM, Ko MK, Im GH, Lee JH, Lee IS. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery. Angew Chem Int Ed Engl 2009; 48:321-324.
19. Ha TL, Kim HJ, Shin J, Im GH, Lee JW, Heo H, et al. Development of targetspecific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform. Chem Commun (Camb) 2011; 47:9176-9178.
20. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue betaamyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet 2004; 13:159-170.
21. Sawiak SJ, Wood NI, Williams GB, Morton AJ, Carpenter TA. SPMmouse: a new toolbox for SPM in the animal brain. Proc Intl Soc Mag Res Med 2009;1086.
22. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 1998; 4:97-100.